Leavitt, Randi Y.

Top Publications

Top Publications Authored or Co-Authored by "Leavitt, Randi Y."

• Raltegravir once daily or twice daily in previously untreated patients with HIV-1: A randomised, active-controlled, phase 3 non-inferiority trial

  The Lancet Infectious Diseases, Volume 11, No. 12, Year 2011, Citations 207
• Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study

  The Lancet HIV, Volume 6, No. 9, Year 2019, Citations 54
• Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy

  PLoS ONE, Volume 9, No. 3, Article e90485, Year 2014, Citations 39
• Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

  The Lancet HIV, Volume 4, No. 11, Year 2017, Citations 34
• Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

  Journal of Antimicrobial Chemotherapy, Volume 71, No. 4, Year 2016, Citations 24